Search for: "J. Bayer" Results 1 - 20 of 244
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 May 2017, 10:48 am by Jay W. Belle Isle
Bellwether trials are a means for parties and attorneys to test their arguments and The post First Xarelto Bellwether Results in Victory for Bayer/J&J appeared first on Legal Reader. [read post]
10 Dec 2014, 11:48 am by Pete Strom
Xarelto Manufacturers Johnson & Johnson and Bayer Fight Consolidation of Lawsuits Bayer and Johnson & Johnson are fighting the consolidation of personal injury and wrongful death lawsuits that claim Xarelto, the companies’ leading anticoagulant, is more dangerous than advertising claims. [read post]
4 Sep 2013, 3:32 am by Lawrence B. Ebert
Hausinger, Alcaligenes eutrophus JMP134 “2,4- Dichlorophenoxyacetate Monooxygenase” Is an α- Ketoglutarate-Dependent Dioxygenase, 175 J. [read post]
15 Jun 2016, 7:09 am by Dr. Shezad Malik
So far, Xarelto brought in about $2 billion for Bayer and J&J in 2015 alone. [read post]
29 Mar 2009, 4:05 pm
” “J & J and partner Bayer have asked the FDA to clear their once-daily pill to stop blood clots in the legs of patients who have undergone hip or knee replacement surgery. [read post]
10 Jan 2018, 11:04 am by Dr. Shezad Malik
The first Xarelto Bleeding Injury plaintiff’s victory against Bayer and Johnson & Johnson (J&J) over Xarelto’s bleeding risks was short lived. [read post]
10 Jan 2018, 11:04 am by Dr. Shezad Malik
The first Xarelto Bleeding Injury plaintiff’s victory against Bayer and Johnson & Johnson (J&J) over Xarelto’s bleeding risks was short lived. [read post]
21 May 2013, 4:45 am by Ed Silverman
A non-profit group put Bayer on notice that a lawsuit will be filed charging the drugmaker with making “unsubstantiated and illegal claims” about the ability of its One-A-Day vitamin to prevent various disease, such as breast cancer, bolster physical energy and improve immunity, among other things. [read post]
11 Dec 2017, 12:39 pm by Jay W. Belle Isle
Last week, Johnson & Johnson (J&J) and Bayer AG had the first loss in the many Xarelto bleeding risk lawsuits. [read post]
30 Mar 2010, 2:12 pm by Tom Lamb
From it we learn that Bayer will update the prescribing information -- also referred to as the package insert, or label -- for Yasmin (drospirenone / ethinylestradiol) in the EU to include results of the following four epidemiological studies: 1) Dinger, Jürgen et al.: The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation. [read post]
2 Mar 2007, 3:50 am
Bayer, 399 F. 3d 1010, as amended, 408 F. 3d 1127 (2005) (McKeown, J.), rehearing en banc denied, 418 F.3d 1055 (2005).The case is: Whorton v. [read post]